ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 68 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $178,000 | +134.2% | 126,000 | +100.0% | 0.01% | +40.0% |
| Q2 2020 | $76,000 | +2.7% | 63,000 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $74,000 | -44.4% | 63,000 | 0.0% | 0.01% | -36.8% |
| Q4 2019 | $133,000 | -4.3% | 63,000 | 0.0% | 0.02% | -17.4% |
| Q3 2019 | $139,000 | -12.6% | 63,000 | 0.0% | 0.02% | -39.5% |
| Q2 2019 | $159,000 | – | 63,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |